The role of the thymus in hematopoietic stem cell transplantation

Bone Marrow Transplantation Across Major Genetic Barriers

Volumn , Issue , 2010, Pages 1-492

  Krenger, Werner ^a   Holländer, Georg A ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84986538264     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1057/9789814271271_0014     Document Type: Chapter

References (222)

1. Mackall CL. (2000) T-cell immunodeficiency following cytotoxic antineoplastic therapy: A review. Stem Cells18: 10-18.
2. Haynes BF, Markert ML, Sempowski GD et al.(2000) The role of the thymus in immune reconstitution in aging, bone marrow transplantation, and HIV-1 infection. Annu Rev Immunol18: 529-560.
3. Weinberg K, Blazar BR, Wagner JE et al.(2001) Factors affecting thymic function after allogeneic hematopoietic stem cell transplantation. Blood97: 1458-1466.
4. Van den Brink MR, Alpdogan O, Boyd RL. (2004) Strategies to enhance T-cell reconstitution in immunocompromised patients. Nat Rev Immunol4: 856-867.
5. Auletta JJ, Lazarus HM. (2005) Immune restoration following hematopoietic stem cell transplantation: An evolving target. Bone Marrow Transplant35: 835-857.
6. Antin JH. (2005) Immune reconstitution: The major barrier to successful stem cell transplantation. Biol Blood Marrow Transplant11: 43-45.
7. Muraro PA, Douek DC. (2006) Renewing the T cell repertoire to arrest autoimmune aggression. Trends Immunol27: 61-67.
8. Crooks GM, Weinberg K, Mackall C. (2006) Immune reconstitution: from stem cells to lymphocytes. Biol Blood Marrow Transplant12: 42-46.
9. Peggs KS. (2006) Reconstitution of adaptive and innate immunity following allogeneic hematopoietic stem cell transplantation in humans. Cytotherapy8: 427-436.
10. Welniak LA, Blazar BR, Murphy WJ. (2007) Immunobiology of allogeneic hematopoietic stem cell transplantation. Annu Rev Immunol25: 139-170.
11. Chidgey A, Dudakov J, Seach N, Boyd R. (2007) Impact of niche aging on thymic regeneration and immune reconstitution. Semin Immunol19: 331-340.
12. Zakrzewski JL, Goldberg GL, Smith OM, Van den Brink MRM. (2008) Enhancing T cell reconstitution after hematopoietic stem cell transplantation: A brief update of the latest trends. Blood Cells Mol Dis40: 44-47.
13. Toubert A. (2008) Immune reconstitution after allogeneic HSCT. In Hematopoietic Stem Cell Transplantation European School of Haematology, Paris.
14. Krenger W, Hollander GA. (2008) The thymus in GVHD pathophysiology. Best Pract Res Clin Haematol21: 119-128.
15. Storek J. (2008) Immunological reconstitution after hematopoietic cell transplantation - its relation to the contents of the graft. Expert Opin Biol Ther8: 583-597.
16. Small TN, Papadopoulos EB, Boulad F et al.(1999) Comparison of immune reconstitution after unrelated and related T-cell-depleted bone marrow transplantation: Effect of patient age and donor leukocyte infusions. Blood93: 467-480.
17. Haddad E, Landais P, Friedrich W et al.(1998) Long-term immune reconstitution and outcome after HLA-nonidentical T-cell-depleted bone marrow transplantation for severe combined immunodeficiency: A European retrospective study of 116 patients. Blood91: 3646-3653.
18. Porrata LF, Litzow MR, Tefferi A et al.(2002) Early lymphocyte recovery is a predictive factor for prolonged survival after autologous hematopoietic stem cell transplantation for acute myelogenous leukemia. Leukemia16: 1311-1318.
19. Clave E, Rocha V, Talvensaari K et al.(2005) Prognostic value of pretransplantation host thymic function in HLA-identical sibling hematopoietic stem cell transplantation. Blood105: 2608-2613.
20. Parkman R, Cohen G, Carter SL et al.(2006) Successful immune reconstitution decreases leukemic relapse and improves survival in recipients of unrelated cord blood transplantation. Biol Blood Marrow Transplant12: 919-927.
21. Ege H, Gertz MA, Markovic SN et al.(2008) Prediction of survival using absolute lymphocyte count for newly diagnosed patients with multiple myeloma: A retrospective study. Br J Haematol141: 792-798.
22. Gill J, Malin M, Sutherland J et al.(2003) Thymic generation and regeneration. Immunol Rev195: 28-50.
23. Guidos C. (2006) Thymus and T-lymphocyte development: What is new in the 21st century?Immunol Rev209: 5-9.
24. Hollander G, Gill J, Zuklys S et al.(2006) Cellular and molecular events during early thymus development. Immunol Rev209: 28-46.
25. Boehm T. (2008) Thymus development and function. Curr Opin Immunol20: 178-184.
26. Rothenberg EV, Moore JE, Yui MA (2008) Launching the T-cell-lineage developmental programme. Nat Rev Immunol8: 9-21.
27. Anderson G, Lane PJ, Jenkinson EJ (2007) Generating intrathymic microenvironments to establish T-cell tolerance. Nat Rev Immunol7: 954-963.
28. Rodewald HR. (2008) Thymus organogenesis. Annu Rev Immunol26: 355-388.
29. Palmer E. (2003) Negative selection-clearing out the bad apples from the T-cell repertoire. Nat Rev Immunol3: 383-391.
30. Petrie HT, Zuniga-Pflucker JC. (2007) Zoned out: Functional mapping of stromal signaling microenvironments in the thymus. Annu Rev Immunol25: 649-679.
31. Gabor MJ, Scollay R, Godfrey DI. (1997) Thymic T cell export is not influenced by the peripheral T cell pool. Eur J Immunol27: 2986-2993.
32. Michie CA, McLean A, Alcock C, Beverley PC. (1992) Lifespan of human lymphocyte subsets defined by CD45 isoforms. Nature360: 264-265.
33. Picker LJ, Treer JR, Ferguson-Darnell B et al.(1993) Control of lymphocyte recirculation in man. I. Differential regulation of the peripheral lymph node homing receptor L-selectin on T cells during the virgin to memory cell transition. J Immunol150: 1105-1121.
34. McFarland RD, Douek DC, Koup RA, Picker LJ. (2000) Identification of a human recent thymic emigrant phenotype. Proc Natl Acad Sci USA97: 4215-4220.
35. Peggs KS, Mackinnon S. (2004) Immune reconstitution following hematopoietic stem cell transplantation. Br J Haematol124: 407-420.
36. Douek DC, McFarland RD, Keiser PH et al.(1998) Changes in thymic function with age and during the treatment of HIV infection. Nature396: 690-695.
37. Douek DC, Koup RA, McFarland RD et al.(2000) Effect of HIV on thymic function before and after antiretroviral therapy in children. J Infect Dis181: 1479-1482.
38. Douek DC, Vescio RA, Betts MR et al.(2000) Assessment of thymic output in adults after haematopoietic stem-cell transplantation and prediction of T-cell reconstitution. Lancet355: 1875-1881.
39. Patel DD, Gooding ME, Parrott RE et al.(2000) Thymic function after hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency. N Engl J Med342: 1325-1332.
40. Markert ML, Hicks CB, Bartlett JA et al.(2000) Effect of highly active antiretroviral therapy and thymic transplantation on immunoreconstitution in HIV infection. AIDS Res Hum Retroviruses16: 403-413.
41. Steffens CM, Al-Harthi L, Shott S et al.(2000) Evaluation of thymopoiesis using T cell receptor excision circles (TRECs): differential correlation between adult and pediatric TRECs and naive phenotypes. Clin Immunol97: 95-101.
42. Storek J, Joseph A, Dawson MA et al.(2002) Factors influencing T-lymphopoiesis after allogeneic hematopoietic cell transplantation. Transplantation73: 1154-1158.
43. Hochberg EP, Chillemi AC, Wu CJ. (2001) Quantitation of T-cell neogenesis in vivo after allogeneic bone marrow transplantation. Blood98: 1116-1121.
44. Lewin SR, Heller G, Zhang L et al.(2002) Direct evidence for new T-cell generation by patients after either T-cell-depleted or unmodified allogeneic hematopoietic stem cell transplantation. Blood100: 2235-2242.
45. Hakim FT, Gress RE. (2002) Reconstitution of thymic function after stem cell transplantation in humans. Curr Opin Hematol9: 490-496.
46. Hazenberg MD, Otto SA, de Pauw ES et al.(2002) T-cell receptor excision circle and T-cell dynamics after allogeneic stem cell transplantation are related to clinical events. Blood99: 3449-3353.
47. Ye P, Kirschner DE. (2002) Reevaluation of T cell receptor excision circles as a measure of human recent thymic emigrants. J Immunol169: 4968-4979.
48. Svaldi M, Lanthaler AJ, Dugas M et al.(2003) T-cell receptor excision circles: A novel prognostic parameter for the outcome of transplantation in multiple myeloma patients. Br J Haematol122: 795-801.
49. Hazenberg MD, Borghans JA, de Boer RJ, Miedema F. (2003) Thymic output: A bad TREC record. Nat Immunol4: 97-99.
50. Ribeiro RM, Perelson AS. (2007) Determining thymic output quantitatively: Using models to interpret experimental T-cell receptor excision circle (TREC) data. Immunol Rev216: 21-34.
51. Dion ML, Poulin JF, Bordi R et al.(2004) HIV infection rapidly induces and maintains a substantial suppression of thymocyte proliferation. Immunity21: 757-768.
52. Fry TJ. (2009) Is a little GVHD a good thing?Blood113: 6274-6275.
53. Almeida AR, Borghans JA, Freitas AA. (2001) T cell homeostasis: Thymus regeneration and peripheral T cell restoration in mice with a reduced fraction of competent precursors. J Exp Med194: 591-599.
54. Jamieson BD, Douek DC, Killian S et al.(1999) Generation of functional thymocytes in the human adult. Immunity10: 569-575.
55. Douek DC, Koup RA. (2000) Evidence for thymic function in the elderly. Vaccine18: 1638-1641.
56. Hakim FT, Memon SA, Cepeda R et al.(2005) Age-dependent incidence, time course, and consequences of thymic renewal in adults. J Clin Invest115: 930-939.
57. Ortman CL, Dittmar KA, Witte PL, Le PT. (2002) Molecular characterization of the mouse involuted thymus: Aberrations in expression of transcription regulators in thymocyte and epithelial compartments. Int Immunol14: 813-822.
58. Gray D, Seach N, Ueno T et al.(2006) Developmental kinetics, turnover, and stimulatory capacity of thymic epithelial cells. Blood108: 3777-3785.
59. Taub DD, Longo DL. (2005) Insights into thymic aging and regeneration. Immunol Rev205: 72-93.
60. Hakim FT, Gress RE. (2007) Immunosenescence: Deficits in adaptive immunity in the elderly. Tissue Antigens70: 179-189.
61. Hakim FT, Gress RE. (2007) Thymic involution: Implications for self-tolerance. Methods Mol Biol380: 377-390.
62. Rossi S, Blazar BR, Farrell CL et al.(2002) Keratinocyte growth factor preserves normal thymopoiesis and thymic microenvironment during experimental graft-versus-host disease. Blood100: 682-691.
63. Rossi SW, Jeker LT, Ueno T et al.(2007) Keratinocyte growth factor (KGF) enhances postnatal T-cell development via enhancements in proliferation and function of thymic epithelial cells. Blood109: 3803-3811.
64. Anderson MS, Venanzi ES, Klein L et al.(2002) Projection of an immunological self shadow within the thymus by the Aire protein. Science298: 1395-1401.
65. Derbinski J, Gabler J, Brors B et al.(2005) Promiscuous gene expression in thymic epithelial cells is regulated at multiple levels. J Exp Med202: 33-45.
66. Kyewski B, Klein L. (2006) A central role for central tolerance. Annu Rev Immunol24: 571-606.
67. Anderson MS, Venanzi ES, Chen Z et al.(2005) The cellular mechanism of Aire control of T cell tolerance. Immunity23: 227-239.
68. Pereira LE, Bostik P, Ansari AA. (2005) The development of mouse APECED models provides new insight into the role of AIRE in immune regulation. Clin Dev Immunol12: 211-216.
69. Park Y, Moon Y, Chung HY. (2003) AIRE-1 (autoimmune regulator type 1) as a regulator of the thymic induction of negative selection. Ann NY Acad Sci1005: 431-435.
70. Liston A, Gray DH, Lesage S et al.(2004) Gene dosage - limiting role of Aire in thymic expression, clonal deletion, and organ-specific autoimmunity. J Exp Med200: 1015-1026.
71. Fontenot JD, Rudensky AY. (2005) A well-adapted regulatory contrivance: Regulatory T cell development and the forkhead family transcription factor Foxp3. Nat Immunol6: 331-337.
72. Von Boehmer H. (2005) Mechanisms of suppression by suppressor T cells. Nat Immunol6: 338-344.
73. Miyara M, Sakaguchi S. (2007) Natural regulatory T cells: Mechanisms of suppression. Trends Mol Med13: 108-116.
74. Aschenbrenner K, D’Cruz LM, Vollmann EH et al.(2007) Selection of Foxp3+ regulatory T cells specific for self antigen expressed and presented by Aire+ medullary thymic epithelial cells. Nat Immunol8: 351-358.
75. Nomura T, Sakaguchi S. (2007) Foxp3 and Aire in thymus-generated Treg cells: A link in self-tolerance. Nat Immunol8(4): 333-334.
76. Hakim FT, Gress RE. (2005) Reconstitution of the lymphocyte compartment after lymphocyte depletion: A key issue in clinical immunology. Eur J Immunol35: 3099-3102.
77. Williams KM, Hakim FT, Gress RE. (2007) T cell immune reconstitution following lymphodepletion. Semin Immunol19: 318-330.
78. Mackall CL, Granger L, Sheard MA et al.(1993) T-cell regeneration after bone marrow transplantation: Differential CD45 isoform expression on thymic-derived versus thymic-independent progeny. Blood82: 2585-2594.
79. Bahceci E, Epperson D, Douek DC et al.(2003) Early reconstitution of the T-cell repertoire after non-myeloablative peripheral blood stem cell transplantation is from post-thymic T-cell expansion and is unaffected by graft-versus-host disease or mixed chimerism. Br J Haematol122: 934-943.
80. Fallen PR, McGreavey L, Madrigal JA et al.(2003) Factors affecting reconstitution of the T-cell compartment in allogeneic hematopoietic cell transplant recipients. Bone Marrow Transplant32: 1001-1014.
81. Jameson SC. (2005) T cell homeostasis: Keeping useful T cells alive and live T cells useful. Semin Immunol17: 231-237.
82. Parkman R, Weinberg KI. (1997) Immunological reconstitution following bone marrow transplantation. Immunol Rev157: 73-78.
83. De Gast GC, Verdonck LF, Middeldorp JM et al.(1985) Recovery of T cell subsets after autologous bone marrow transplantation is mainly due to proliferation of mature T cells in the graft. Blood66: 428-431.
84. Gaschet J, Denis C, Milpied N et al.(1995) Alterations of T cell repertoire after bone marrow transplantation: Characterization of over-represented subsets. Bone Marrow Transplant16: 427-435.
85. Brugnoni D, Airo P, Pennacchio M et al.(1999) Immune reconstitution after bone marrow transplantation for combined immunodeficiencies: Down-modulation of Bcl-2 and high expression of CD95/Fas account for increased susceptibility to spontaneous and activation-induced lymphocyte cell death. Bone Marrow Transplant23: 451-457.
86. Lin MT, Tseng LH, Frangoul H et al.(2000) Increased apoptosis of peripheral blood T cells following allogeneic hematopoietic cell transplantation. Blood95: 3832-3839.
87. Brochu S, Rioux-Mass B, Roy J et al.(1999) Massive activation-induced cell death of alloreactive T cells with apoptosis of bystander postthymic T cells prevents immune reconstitution in mice with graft-versus-host disease. Blood94: 390-400.
88. Curtis RE, Travis LB, Rowlings PA et al.(1999) Risk of lympho-proliferative disorders after bone marrow transplantation: A multi-institutional study. Blood94: 2208-2216.
89. Wagner JE, Thompson JS, Carter SL, Kernan NA. (2005) Effect of graft-versus-host disease prophylaxis on 3-year disease-free survival in recipients of unrelated donor bone marrow (T-cell depletion trial): A multi-centre, randomised phase II-III trial. Lancet366: 733-741.
90. E. Einsele. (2005) T-cell therapy for viral and fungal infections. Blood106: 4023.
91. Gress RE, Komanduri KV, Einsele H, Cooper LJ. (2007) Lymphoid reconstruction and vaccines. Biol Blood Marrow Transplant13: 17-22.
92. Heitger A, Neu N, Kern H et al.(1997) Essential role of the thymus to reconstitute naive (CD45RA+) T-helper cells after human allogeneic bone marrow transplantation. Blood90: 850-857.
93. Heitger A, Greinix H, Mannhalter C et al.(2000) Requirement of residual thymus to restore normal T-cell subsets after human allogeneic bone marrow transplantation. Transplantation69: 2366-2373.
94. Klein AK, Patel DD, Gooding ME et al.(2001) T-cell recovery in adults and children following umbilical cord blood transplantation. Biol Blood Marrow Transplant7: 454-466.
95. Chen X, Barfield R, Benaim E et al.(2005) Prediction of T-cell reconstitution by assessment of T-cell receptor excision circle before allogeneic hematopoietic stem cell transplantation in pediatric patients. Blood105: 886-893.
96. Sato K, Ohtsuka K, Hasegawa K et al.(1995) Evidence for extrathymic generation of intermediate T cell receptor cells in the liver revealed in thymectomized, irradiated mice subjected to bone marrow transplantation. J Exp Med182: 759-767.
97. Mackall CL, Fleisher TA, Brown MR et al.(1995) Age, thy-mopoiesis, and CD4+ T-lymphocyte regeneration after intensive chemotherapy. N Engl J Med332: 143-149.
98. Hara M, McAdams HP, Vredenburgh JJ et al.(1999) Thymic hyperplasia after high-dose chemotherapy and autologous stem cell transplantation: Incidence and significance in patients with breast cancer. AJR Am J Roentgenol173: 1341-1344.
99. Scollay R, Godfrey DI. (1995) Thymic emigration: Conveyor belts or lucky dips?Immunol Today16: 268-273.
100. Benz C, Martins VC, Radtke F, Bleul CC. (2008) The stream of precursors that colonizes the thymus proceeds selectively through the early T lineage precursor stage of T cell development. J Exp Med205: 1187-1199.
101. Weinberg K, Annett G, Kashyap A et al.(1995) The effect of thymic function on immunocompetence following bone marrow transplantation. Biol Blood Marrow Transplant1: 18-23.
102. Kook H, Goldman F, Padley D et al.(1996) Reconstruction of the immune system after unrelated or partially matched T-cell-depleted bone marrow transplantation in children: immunophenotypic analysis and factors affecting the speed of recovery. Blood88: 1089-1097.
103. Dumont-Girard F, Roux E, van Lier RA et al.(1998) Reconstitution of the T-cell compartment after bone marrow transplantation: Restoration of the repertoire by thymic emigrants. Blood92: 4464-4471.
104. Douek DC. (2002) The contribution of the thymus to immune reconstitution after hematopoietic stem-cell transplantation. Cytotherapy4: 425-426.
105. Roux E, Dumont-Girard F, Starobinski M et al.(2000) Recovery of immune reactivity after T-cell-depleted bone marrow transplantation depends on thymic activity. Blood96: 2299-2303.
106. Storek J, Dawson MA, Storer B et al.(2001) Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantation. Blood97: 3380-3389.
107. Muraro PA, Douek DC, Packer A et al.(2005) Thymic output generates a new and diverse TCR repertoire after autologous stem cell transplantation in multiple sclerosis patients. J Exp Med201: 805-816.
108. Fry TJ, Mackall CL. (2005) Immune reconstitution following hematopoietic progenitor cell transplantation: Challenges for the future. Bone Marrow Transplant35(Suppl. 1): 53-57.
109. Mackall CL, Gress RE. (1997) Pathways of T-cell regeneration in mice and humans: Implications for bone marrow transplantation and immunotherapy. Immunol Rev157: 61-72.
110. Storek J, Joseph A, Espino G et al.(2001) Immunity of patients surviving 20 to 30 years after allogeneic or syngeneic bone marrow transplantation. Blood98: 3505-3512.
111. Mackall CL, Stein D, Fleisher TA et al.(2000) Prolonged CD4 depletion after sequential autologous peripheral blood progenitor cell infusions in children and young adults. Blood96: 754-762.
112. Komanduri KV, St John LS, De Lima M et al.(2007) Delayed immune reconstitution after cord blood transplantation is characterized by impaired thymopoiesis and late memory T-cell skewing. Blood110: 4543-4551.
113. Hentschke P, Omazic B, Mattsson J et al.(2005) T-cell receptor V@ repertoire after myeloablative and reduced intensity conditioning allogeneic haematopoietic stem cell transplantation. Scand J Immunol61: 285-294.
114. Pannetier C, Cochet M, Darche S et al.(1993) The sizes of the CDR3 hypervariable regions of the murine T-cell receptor beta chains vary as a function of the recombined germ-line segments. Proc Natl Acad Sci USA90: 4319-4323.
115. Gorski J, Yassai M, Zhu X et al.(1994) Circulating T cell repertoire complexity in normal individuals and bone marrow recipients analyzed by CDR3 size spectratyping: Correlation with immune status. J Immunol152: 5109-5119.
116. Mackall CL, Hakim FT, Gress RE. (1997) T-cell regeneration: all repertoires are not created equal. Immunol Today18: 245-251.
117. Roux E, Helg C, Dumont-Girard F et al.(1996) Analysis of T-cell repopulation after allogeneic bone marrow transplantation: Significant differences between recipients of T-cell depleted and unmanipulated grafts. Blood87: 3984-3992.
118. Talvensaari K, Clave E, Douay C et al.(2002) Abroad T-cell repertoire diversity and an efficient thymic function indicate a favorable long-term immune reconstitution after cord blood stem cell transplantation. Blood99: 1458-1464.
119. Godthelp BC, van Tol MJ, Vossen JM, van Den Elsen PJ. (1999) T-cell immune reconstitution in pediatric leukemia patients after allogeneic bone marrow transplantation with T-cell-depleted or unmanipulated grafts: Evaluation of overall and antigen-specific T-cell repertoires. Blood94: 4358-4369.
120. Eyrich M, Croner T, Leiler C et al. (2002) Distinct contributions of CD4+ and CD8+ naive and memory T-cell subsets to overall T-cell-receptor repertoire complexity following transplantation of T-cell-depleted CD34-selected hematopoietic progenitor cells from unrelated donors.Blood100: 1915-1918.
121. Dey BR, Spitzer TR. (2006) Current status of haploidentical stem cell transplantation. Br J Haematol135: 423-437.
122. Koh LP, Chao NJ. (2008) Nonmyeloablative allogeneic hematopoietic stem cell transplant using mismatched/haploidentical donors: A review. Blood Cells Mol Dis40: 20-24.
123. Aversa F. (2008) Haploidentical haematopoietic stem cell transplantation for acute leukaemia in adults: Experience in Europe and the United States. Bone Marrow Transplant41: 473-481.
124. Laufer TM, DeKoning J, Markowitz JS et al.(1996) Unopposed positive selection and autoreactivity in mice expressing class II MHC only on thymic cortex. Nature383: 81-85.
125. Laufer TM, Fan L, Glimcher LH. (1999) Self-reactive T cells selected on thymic cortical epithelium are polyclonal and are pathogenicin vivo. J Immunol162: 5078-5084.
126. Tivol E, Komorowski R, Drobyski WR. (2005) Emergent autoimmunity in graft-versus-host disease. Blood105: 4885-4891.
127. Teshima T, Reddy P, Liu C et al.(2003) Impaired thymic negative selection causes autoimmune graft-versus-host disease. Blood102: 429-435.
128. Sakoda Y, Hashimoto D, Asakura S et al.(2007) Donor-derived thymic-dependent T cells cause chronic graft-versus-host disease. Blood109: 1756-1764.
129. Knobloch C, Friedrich W. (1991) T cell receptor diversity in severe combined immunodeficiency following HLA-haploidentical bone marrow transplantation. Bone Marrow Transplant8: 383-387.
130. Sarzotti M, Patel DD, Li X et al.(2003) T cell repertoire development in humans with SCID after nonablative allogeneic marrow transplantation. J Immunol170: 2711-2718.
131. Woodard P, Cunningham JM, Benaim E et al.(2004) Effective donor lymphohematopoietic reconstitution after haploidentical CD34+-selected hematopoietic stem cell transplantation in children with refractory severe aplastic anemia. Bone Marrow Transplant33: 411-418.
132. Caillat-Zucman S, Le Deist F, Haddad E et al. (2004) Impact of HLA matching on outcome of hematopoietic stem cell transplantation in children with inherited diseases: A single-center comparative analysis of genoidentical, haploidentical or unrelated donors. Bone Marrow Transplant33(11): 1089-1095.
133. Chen X, Hale GA, Barfield R et al.(2006) Rapid immune reconstitution after a reduced-intensity conditioning regimen and a CD3-depleted haploidentical stem cell graft for paediatric refractory haematological malignancies. Br J Haematol135: 524-532.
134. Friedrich W, Honig M, Muller SM. (2007) Long-term follow-up in patients with severe combined immunodeficiency treated by bone marrow transplantation. Immunol Res38: 165-173.
135. Fu YW, Wu de P, Cen JN et al.(2007) Patterns of T-cell reconstitution by assessment of T-cell receptor excision circle and T-cell receptor clonal repertoire after allogeneic hematopoietic stem cell transplantation in leukemia patients - a study in Chinese patients. Eur J Haematol79: 138-145.
136. Touraine JL, Plotnicky H, Roncarolo MG et al. (2007) Immunological lessons learnt from patients transplanted with fully mismatched stem cells. Immunol Res38: 201-209.
137. Verfuerth S, Peggs K, Vyas P et al.(2000) Longitudinal monitoring of immune reconstitution by CDR3 size spectratyping after T-cell-depleted allogeneic bone marrow transplant and the effect of donor lymphocyte infusions on T-cell repertoire. Blood95: 3990-3995.
138. Hashimoto F, Sugiura K, Inoue K, Ikehara S. (1997) Major histocompatibility complex restriction between hematopoietic stem cells and stromal cells in vivo. Blood89: 49-54.
139. Zinkernagel RM, Althage A. (1999) On the role of thymic epithelium vs. bone marrow-derived cells in repertoire selection of T cells. Proc Natl Acad Sci USA96: 8092-8097.
140. Vukmanovic S. (1992) Positive selection of T lymphocytes induced by intrathymic injection of a thymic epithelial cell line. Nature359: 729-732.
141. Hugo P, Kappler JW, McCormack JE, Marrack P. (1993) Fibroblasts can induce thymocyte positive selection in vivo. Proc Natl Acad Sci USA90: 10335-10339.
142. Pawlowski T, Elliott JD, Loh DY, Staerz UD. (1993) Positive selection of T lymphocytes on fibroblasts. Nature364: 642-645.
143. Choi EY, Jung KC, Park HJ et al.(2005) Thymocyte-thymocyte interaction for efficient positive selection and maturation of CD4 T cells. Immunity23: 387-396.
144. Martinic MM, Rulicke T, Althage A et al.(2003) Efficient T cell repertoire selection in tetraparental chimeric mice independent of thymic epithelial MHC. Proc Natl Acad Sci USA100: 1861-1866.
145. Markert ML, Boeck A, Hale LP et al.(1999) Transplantation of thymus tissue in complete DiGeorge syndrome. N Engl J Med341: 1180-1189.
146. Markert ML, Devlin BH, Alexieff MJ et al.(2007) Review of 54 patients with complete DiGeorge anomaly enrolled in protocols for thymus transplantation: Outcome of 44 consecutive transplants. Blood109: 4539-4547.
147. Markert ML, Kostyu DD, Ward FE et al.(1997) Successful formation of a chimeric human thymus allograft following transplantation of cultured postnatal human thymus. J Immunol158: 998-1005.
148. Ochs L, Shu XO, Miller J et al.(1995) Late infections after allogeneic bone marrow transplantations: Comparison of incidence in related and unrelated donor transplant recipients. Blood86: 3979-3986.
149. Wu CJ, Chillemi A, Alyea EP et al.(2000) Reconstitution of T-cell receptor repertoire diversity following T-cell depleted allogeneic bone marrow transplantation is related to hematopoietic chimerism. Blood95: 352-359.
150. Bacigalupo A. (2007) Management of acute graft-versus-host disease. Br J Haematol137: 87-98.
151. Weinberg KI. (2007) Protection from posttransplantation immune deficiency?Blood109: 3617-3618.
152. Sale GE, Alavaikko M, Schaefers KM, Mahan CT. (1992) Abnormal CD4:CD8 ratios and delayed germinal center reconstitution in lymph nodes of human graft recipients with graft-versus-host disease (GVHD): An immunohistological study. Exp Hematol20: 1017-1021.
153. Krenger W, Ferrara JL. (1996) Graft-versus-host disease and the Th1/Th2 paradigm. Immunol Res15: 50-73.
154. Krenger W, Hill GR, Ferrara JL. (1997) Cytokine cascades in acute graft-versus-host disease. Transplantation64: 553-558.
155. Blazar BR, Murphy WJ. (2005) Bone marrow transplantation and approaches to avoid graft-versus-host disease (GVHD). Philos Trans R Soc Lond B Biol Sci360: 1747-1767.
156. Ferrara JL, Reddy P. (2006) Pathophysiology of graft-versus-host disease. Semin Hematol43: 3-10.
157. Shlomchik WD. (2007) Graft-versus-host disease. Nat Rev Immunol7: 340-352.
158. Riddell SR, Appelbaum FR. (2007) Graft-versus-host disease: a surge of developments. PLoS Med4: 1174-1177.
159. Krenger W, Snyder KM, Byon JC et al. (1995) Polarized type 2 alloreactive CD4+ and CD8+ donor T cells fail to induce experimental acute graft-versus-host disease. J Immunol1995; 155: 585-593.
160. Krenger W, Falzarano G, Delmonte J et al.(1996) Interferon-gamma suppresses T-cell proliferation to mitogen via the nitric oxide pathway during experimental acute graft-versus-host disease. Blood88: 1113-1121.
161. Krenger W, Rossi S, Piali L, Hollander GA. (2000) Thymic atrophy in murine acute graft-versus-host disease is effected by impaired cell cycle progression of host pro-T and pre-T cells. Blood96: 347-354.
162. Hauri-Hohl MM, Keller MP, Gill J et al.(2007) Donor T-cell allore-activity against host thymic epithelium limits T-cell development after bone marrow transplantation. Blood109: 4080-4088.
163. Ferrara JLM. (2006) GVHD: In vivo veritas. Blood106: 772-773.
164. Dulude G, Roy DC, Perreault C. (1999) The effect of graft-versus-host disease on T cell production and homeostasis. J Exp Med189: 1329-1342.
165. Beschorner WE, Hutchins GM, Elfenbein GJ, Santos GW. (1978) The thymus in patients with allogeneic bone marrow transplants. AmJ Pathol92: 173-181.
166. Seddik M, Seemayer TA, Lapp WS. (1980) T cell functional defect associated with thymic epithelial cell injury induced by a graft-versus-host reaction. Transplantation29: 61-66.
167. Seemayer TA, Lapp WS, Bolande RP. (1978) Thymic epithelial injury in graft-versus-host reactions following adrenalectomy. Am J Pathol93: 325-338.
168. Lapp WS, Ghayur T, Mendez M et al.(1985) The functional and histological basis for graft-versus-host-induced immunosuppression. Immunol Rev88: 107.
169. Ghayur T, Seemayer T, Lapp WS et al.(1990) Histologic correlates of immune functional deficits in graft-vs.-host disease. In: Burakoff SJ, Deeg HJ, Ferrara J, Atkinson K (eds.) Graft-vs.-Host Disease: Immunology, Pathophysiology, and Treatment, pp. 109-132. Marcel Dekker, New York.
170. Seemayer TA, Bolande RP. (1980) Thymic involution mimicking thymic dysplasia: A consequence of transfusion-induced graft versus host disease in a premature infant. Arch Pathol Lab Med104: 141-144.
171. Gartner JG. (1991) Thymic involution with loss of Hassall’s corpuscles mimicking thymic dysplasia in a child with transfusion-associated graft-versus-host disease. Pediatr Pathol11: 449-456.
172. Clave E, Busson M, Douay C et al. (2009) Acute graft versus host disease transiently impairs thymic output in young patients after allogeneic hematopoietic stem cell transplantation. Blood113: 6477-6484.
173. Krenger W, Schmidlin H, Cavadini G, Hollander GA. (2004) On the relevance of TCR rearrangement circles as molecular markers for thymic output during experimental graft-versus-host disease. J Immunol172: 7359-7367.
174. Seemayer TA, Lapp WS, Bolande RP. (1977) Thymic involution in murine graft-versus-host reaction: Epithelial injury mimicking human thymic dysplasia. Am J Pathol88: 119-133.
175. Fukuzawa M, Via CS, Shearer GM. (1988) Defective thymic education of L3T4+ T helper cell function in graft-vs-host mice. J Immunol141: 430-439.
176. Ghayur T, Seemayer TA, Xenocostas A, Lapp WS. (1988) Complete sequential regeneration of graft-vs.-host-induced severely dysplastic thymuses: Implications for the pathogenesis of chronic graft-vs.-host disease. Am J Pathol133: 39-46.
177. Fukushi N, Arase H, Wang B et al.(1990) Thymus: A direct target tissue in graft-versus-host reaction after allogeneic bone marrow transplantation that results in abrogation of induction of selftolerance. Proc Natl Acad Sci USA87: 6301-6305.
178. Desbarats J, Lapp WS. (1993) Thymic selection and thymic major histocompatibility complex class II expression are abnormal in mice undergoing graft-versus-host reactions. J Exp Med178: 805-814.
179. Hollander GA, Widmer B, Burakoff SJ. (1994) Loss of normal thymic repertoire selection and persistence of autoreactive T cells in graft vs. host disease. J Immunol152: 1609-1617.
180. Van den Brink MR, Moore E, Ferrara JL, Burakoff SJ. (2000) Graft-versus-host-disease-associated thymic damage results in the appearance of T cell clones with anti-host reactivity. Transplantation69: 446-449.
181. Morohashi T, Ogasawara K, Kitaichi N et al.(2000) Abrogation of negative selection by GVHR induced by minor histocompatibility antigens or H-2D antigen alone. Immunobiology202: 268-279.
182. Krenger W, Rossi S, Hollander GA. (2000) Apoptosis of thymocytes during acute graft-versus-host disease is independent of glucocorticoids. Transplantation69: 2190-2193.
183. Huiskamp R, van Ewijk W. (1985) Repopulation of the mouse thymus after sublethal fission neutron irradiation. I. Sequential appearance of thymocyte subpopulations. J Immunol134: 2161-2219.
184. Huiskamp R, Davids JA, van Ewijk W. (1988) The effect of graded doses of fission neutrons or X rays on the stromal compartment of the thymus in mice. Radiat Res113: 25-39.
185. Kumamoto T, Inaba M, Toki J et al.(1995) Cytotoxic effects of irradiation and deoxyguanosine on fetal thymus. Immunobiology192: 365-381.
186. Via CS, Sharrow SO, Shearer GM. (1987) Role of cytotoxic T lymphocytes in the prevention of lupus-like disease occurring in a murine model of graft-versus-host disease. J Immunol139: 1840-1849.
187. Via CS, Finkelman FD. (1993) Critical role of interleukin-2 in the development of acute graft-versus-host disease. Int Immunol5: 565-572.
188. Via CS, Rus V, Gately MK, Finkelman FD. (1994) IL-12 stimulates the development of acute graft-versus-host disease in mice that would normally develop chronic, autoimmune graft-versus-host disease. J Immunol153: 4040-4047.
189. Garside P, Reid S, Steel M, Mowat AM. (1994) Differential cytokine production associated with distinct phases of murine graft-versus-host reaction. Immunology82: 211-214.
190. Daikeler T, Tyndall A. (2007) Autoimmunity following haematopoietic stem-cell transplantation. Best Pract Res Clin Haematol20: 349-360.
191. Filipovich AH, Weisdorf D, Pavletic S et al.(2005) National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant11: 945-956.
192. Mackey JR, Desai S, Larratt L et al.(1997) Myasthenia gravis in association with allogeneic bone marrow transplantation: Clinical observations, therapeutic implications and review of literature. Bone Marrow Transplant19: 939-942.
193. Chu YW, Gress RE. (2008) Murine models of chronic graft-versus-host disease: Insights and unresolved issues. Biol Blood Marrow Transplant14: 365-378.
194. McCormick LL, Zhang Y, Tootell E, Gilliam AC. (1999) Anti-TGF-beta treatment prevents skin and lung fibrosis in murine sclerodermatous graft-versus-host disease: A model for human scleroderma. J Immunol163: 5693-5699.
195. Zhang C, Todorov I, Zhang Z et al.(2006) Donor CD4+ T and B cells in transplants induce chronic graft-versus-host disease with autoimmune manifestations. Blood107: 2993-3001.
196. Anderson BE, McNiff JM, Matte C et al.(2004) Recipient CD4+ T cells that survive irradiation regulate chronic graft-versus-host disease. Blood104: 1565-1573.
197. Zhang Y, Hexner E, Frank D, Emerson SG. (2007) CD4+ T cells generated de novo from donor hemopoietic stem cells mediate the evolution from acute to chronic graft-versus-host disease. J Immunol179:3305-3314.
198. Chen X, Vodanovic-Jankovic S, Johnson B et al.(2007) Absence of regulatory T-cell control of TH1 and TH17 cells is responsible for the autoimmune-mediated pathology in chronic graft-versus-host disease. Blood110: 3804-3813.
199. Goldberg G. (2007) Clinical strategies to enhance T cell reconstitution. Semin Immunol19: 289-296.
200. Adkins B, Gandour D, Strober S, Weissman I. (1988) Total lymphoid irradiation leads to transient depletion of the mouse thymic medulla and persistent abnormalities among medullary stromal cells. J Immunol140: 3373-3379.
201. Chung B, Barbara-Burnham L, Barsky L, Weinberg K. (2001) Radiosensitivity of thymic interleukin-7 production and thy-mopoiesis after bone marrow transplantation. Blood98: 1601-1606.
202. Kelly RM, Highfill SL, Panoskaltsis-Mortari A et al. (2008) Keratinocyte growth factor and androgen blockade work in concert to protect against conditioning regimen-induced thymic epithelial damage and enhance T-cell reconstitution after murine bone marrow transplantation.Blood111: 5734-5744.
203. Van Vliet E, Melis M, Van Ewijk W. (1986) The influence of dexamethasone treatment on the lymphoid and stromal composition of the mouse thymus: A flow cytometric and immunohistological analysis. Cell Immunol103: 229-240.
204. Savino W. (2006) The thymus is a common target organ in infectious diseases. PLoS Pathog2: e62.
205. Finch PW, Rubin JS. (2004) Keratinocyte growth factor/fibroblast growth factor 7, a homeostatic factor with therapeutic potential for epithelial protection and repair. Adv Cancer Res69-115.
206. Radtke ML, Kolesar JM. (2005) Palifermin (Kepivance) for the treatment of oral mucositis in patients with hematologic malignancies requiring hematopoietic stem cell support. J Oncol Pharm Pract11: 121-125.
207. Siddiqui MA, Wellington K. (2005) Palifermin: In myelotoxic therapy-induced oral mucositis. Drugs65: 2139-2146.
208. Alpdogan O, Hubbard VM, Smith OM et al.(2006) Keratinocyte growth factor (KGF) is required for post-natal thymic regeneration. Blood107: 2453-2460.
209. Revest JM, Suniara RK, Kerr K et al.(2001) Development of the thymus requires signaling through the fibroblast growth factor receptor r2-iiib. J Immunol167: 1954-1961.
210. Guo L, Degenstein L, Fuchs E. (1996) Keratinocyte growth factor is required for hair development but not for wound healing. Genes Dev10: 165-175.
211. Min D, Panoskaltsis-Mortari A, Kuro OM et al.(2007) Sustained thymopoiesis and improvement in functional immunity induced by exogenous KGF administration in murine models of aging. Blood109: 2529-2537.
212. Min D, Taylor PA, Panoskaltsis-Mortari A et al. (2002) Protection from thymic epithelial cell injury by keratinocyte growth factor: A new approach to improve thymic and peripheral T-cell reconstitution after bone marrow transplantation. Blood99: 4592-4600.
213. Seggewiss R, Lore K, Guenaga FJ et al.(2007) Keratinocyte growth factor augments immune reconstitution after autologous hematopoietic progenitor cell transplantation in rhesus macaques. Blood110: 441-449.
214. Blazar BR, Weisdorf DJ, DeFor TE et al.(2006) Phase 1/2 randomized, placebo-control trial of palifermin to prevent graft-versus-host disease (GVHD) after allogeneic hematopoietic stem cell transplantation (HSCT). Blood108: 3216-3222.
215. Seggewiss R, Einsele H. (2007) Hematopoietic growth factors including keratinocyte growth factor in allogeneic and autologous stem cell transplantation. Semin Hematol44: 203-211.
216. Heng TS, Goldberg GL, Gray DH et al.(2005) Effects of castration on thymocyte development in two different models of thymic involution. J Immunol175: 2982-2993.
217. Sutherland JS, Goldberg GL, Hammett MV et al.(2005) Activation of thymic regeneration in mice and humans following androgen blockade. J Immunol175: 2741-2753.
218. Olsen NJ, Olson G, Viselli SM et al.(2001) Androgen receptors in thymic epithelium modulate thymus size and thymocyte development. Endocrinology142: 1278-1283.
219. Erickson M, Morkowski S, Lehar S et al.(2002) Regulation of thymic epithelium by keratinocyte growth factor. Blood100: 3269-3278.
220. Suniara RK, Jenkinson EJ, Owen JJ. (2000) An essential role for thymic mesenchyme in early T cell development. J Exp Med191: 1051-1056.
221. Revest JM, Spencer-Dene B, Kerr K et al.(2001) Fibroblast growth factor receptor 2-IIIb acts upstream of Shh and Fgf4 and is required for limb bud maintenance but not for the induction of Fgf8, Fgf10, Msx1, or Bmp4. Dev Biol231: 47-62.
222. Brauchle M, Fassler R, Werner S. (1995) Suppression of keratinocyte growth factor expression by glucocorticoids in vitro and during wound healing. J Invest Dermatol105: 579-584.